ACSF3
Malonate--CoA ligase ACSF3, mitochondrial
Also known as: ACSF3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q4G176
- Gene
- ACSF3
- Ensembl
- ENSG00000176715
- Chromosome
- 16
- Canonical length
- 576 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene encodes a member of the acyl-CoA synthetase family of enzymes that activate fatty acids by catalyzing the formation of a thioester linkage between fatty acids and coenzyme A. The encoded protein is localized to mitochondria, has high specificity for malonate and methylmalonate and possesses malonyl-CoA synthetase activity. Mutations in this gene are a cause of combined malonic and methylmalonic aciduria. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Sep 2013]
Canonical amino-acid sequenceUniProt
576 residues, UniProt reviewed canonical sequence.
>Q4G176|ACSF3
1 MLPHVVLTFR RLGCALASCR LAPARHRGSG LLHTAPVARS DRSAPVFTRA LAFGDRIALV
61 DQHGRHTYRE LYSRSLRLSQ EICRLCGCVG GDLREERVSF LCANDASYVV AQWASWMSGG
121 VAVPLYRKHP AAQLEYVICD SQSSVVLASQ EYLELLSPVV RKLGVPLLPL TPAIYTGAVE
181 EPAEVPVPEQ GWRNKGAMII YTSGTTGRPK GVLSTHQNIR AVVTGLVHKW AWTKDDVILH
241 VLPLHHVHGV VNALLCPLWV GATCVMMPEF SPQQVWEKFL SSETPRINVF MAVPTIYTKL
301 MEYYDRHFTQ PHAQDFLRAV CEEKIRLMVS GSAALPLPVL EKWKNITGHT LLERYGMTEI
361 GMALSGPLTT AVRLPGSVGT PLPGVQVRIV SENPQREACS YTIHAEGDER GTKVTPGFEE
421 KEGELLVRGP SVFREYWNKP EETKSAFTLD GWFKTGDTVV FKDGQYWIRG RTSVDIIKTG
481 GYKVSALEVE WHLLAHPSIT DVAVIGVPDM TWGQRVTAVV TLREGHSLSH RELKEWARNV
541 LAPYAVPSEL VLVEEIPRNQ MGKIDKKALI RHFHPSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACSF3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- thymus: 35 nTPM
- duodenum: 29 nTPM
- small intestine: 25 nTPM
- lymph node: 20 nTPM
- adrenal gland: 19 nTPM
- liver: 18 nTPM
Single-cell type
- tuft cells: 58 nCPM
- enterocytes: 55 nCPM
- late spermatids: 52 nCPM
- hematopoietic stem cells: 46 nCPM
- paneth cells: 43 nCPM
- b-cells: 42 nCPM
Immune cell
- memory B-cell: 30 nTPM
- MAIT T-cell: 25 nTPM
- plasmacytoid DC: 25 nTPM
- classical monocyte: 23 nTPM
- intermediate monocyte: 23 nTPM
- gdT-cell: 23 nTPM
Brain region
- cerebral cortex: 30 nTPM
- white matter: 29 nTPM
- thalamus: 27 nTPM
- cerebellum: 25 nTPM
- choroid plexus: 25 nTPM
- medulla oblongata: 25 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ACSF3.
Disease | AllUniProt
Conditions ACSF3 is implicated in, by any mechanism.
- Combined malonic and methylmalonic aciduria (CMAMMA) MIM:614265
Disease | GeneticClinVar
186 pathogenic / likely-pathogenic of 1,113 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Combined malonic and methylmalonic acidemia
- ACSF3-related disorder
- Methylmalonic acidemia
- Inborn genetic diseases
- Sarcoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.77
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.3
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- fatty acid biosynthetic process
- fatty acid metabolic process
- long-chain fatty-acyl-CoA biosynthetic process
- malonate catabolic process
Molecular functions
- ATP binding
- CoA-ligase activity
- very long-chain fatty acid-CoA ligase activity
- malonyl-CoA synthetase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ACSF3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACSF3 as an antibody target. Whether an autoantibody or antibody against ACSF3 could matter depends on whether native ACSF3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACSF3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACSF3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...